How Mark Cuban is Turning the Prescription Drug Industry Upside Down

When Mark Cuban enters an industry, he typically disrupts it in one way or another. And that’s precisely what it appears he has done once again, though this time in the healthcare space. His Cost Plus Drug Company has turned the industry on its head and introduced transparency to the previously opaque area of prescription drug prices.

“We started [Mark Cuban Cost Plus Drug Company] with the goal of being the low-cost provider for generic drugs,” Cuban told MarketScale. 

The company’s website features a chart displaying the stark difference in the retail price of these drugs versus what consumers pay through their platform. But perhaps the most striking thing about the Cost Plus Drug Company is the clarity of the pricing structure. Leadership has been vocal, on the site and on social media, about how Cost Plus Drugs gets to its final prices in an effort to set a new standard for patient-focused transparency.

For example, every drug is priced with the same markups: a 15% markup supports operations, a $3 charge covers pharmacy labor, and then the usual fixed and variable costs of shipping round out the total. Some savings are minimal; a 60-count of 20mg Fluoxetine, the generic alternative for depression and OCD treatment drug Prozac, costs $4.80 for a Cost Plus Drugs customer, compared to the retail price of $43.80.

Some savings are so stark that they warrant a double take. For a 30-count of 400mg Imatinib, the generic version of leukemia-treatment drug Gleevec, Cost Plus Drugs customers pay $47.50, compared to the retail price of $9,657.40, an enormous difference in cost.

“We will do whatever it takes to get affordable pharmaceuticals to patients,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug. “The markup on potentially lifesaving drugs that people depend on is a problem that can’t be ignored. It is imperative that we take action and help expand access to these medications for those who need them most.”

With this cost savings business model, underinsured or uninsured patients who’d be paying close to or full price would see the most immediate benefits. Even insured patients though, according to the company’s site, would pay “less than what you would pay when using your insurance at a typical pharmacy.”

The cost of drugs in the United States has been a problem for some time, garnering attention from President Biden and putting a financial strain on many Americans. According to Kevin Stevenson, Director of Strategic Operations at Providence Healthcare Network in Waco, TX, affecting positive change in this side of the industry is critical, as for patients, it’s truly a life or death situation.

“People who don’t have insurance that are paying out of pocket, oftentimes they skip medications because they take food out of their family’s mouth,” Stevenson said.

The high-profile attention that Cuban’s company, as well as the issue at-large, is getting could be a sign of things to come for healthcare in the United States.

“I think we’re seeing people in healthcare now that are having that more entrepreneurial mindset, that are looking at problems and saying how can we look at it from a different viewpoint to try to solve this,” he said.

Stevenson admitted that change in healthcare can come slowly, but with sharks like Mark Cuban in the water, change could be coming sooner rather than later. 

Follow us on social media for the latest updates in B2B!

Image

Latest

Mike Dermont Diversified talks AV and healthcare experience
AV’s Critical Role in the Future of Healthcare Experience
July 15, 2025

As healthcare organizations face growing pressure to improve healthcare experience, patient outcomes, streamline operations, and address chronic staffing shortages, audiovisual (AV) technologies are becoming essential tools in delivering high-quality care. From in-room monitoring to patient communication systems, the AV industry is stepping up to meet the evolving demands of a sector that touches every life….

Read More
Applied Digital
Workforce, Housing, and Growth: How Applied Digital Is Revitalizing a Rural Town Through AI Infrastructure
July 15, 2025

As AI infrastructure spreads beyond tech hubs and into America’s heartland, companies face a new imperative: not just to build facilities—but to build trust, local partnerships, and long-term value for the communities that host them. In Ellendale, North Dakota, Applied Digital’s Polaris Forge 1 campus has become a case study in what rural revitalization…

Read More
Sepsis
Challenges of Identifying and Reducing Sepsis Mortality – Episode 2
July 15, 2025

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…

Read More
engineering community
The Future of the Engineering Community: Equity, AI, and Real Connection
July 15, 2025

The Engineer Who Builds Communities, Not Just Systems! Angelie Vincent has spent more than two decades in aerospace engineering, but her real legacy might be the communities she’s built along the way. Now an AI Integration Engineer at Boeing, Angelie joins Professional Quotient host Jason Winningham for a wide-ranging conversation on neurodivergent leadership, workplace…

Read More